Protein arginine methylation in lymphocyte signaling

Current Opinion in Immunology

Volumn 18, Issue 3, 2006, Pages 321-328

  Blanchet, Fabien ^a   Schurter, Brandon T ^a   Acuto, Oreste ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CD28 ANTIGEN; NUCLEIC ACID; PROTEIN ARGININE METHYLTRANSFERASE; TRANSCRIPTION FACTOR NFAT;

CELL FUNCTION; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; PROTEIN FAMILY; PROTEIN METHYLATION; PROTEIN MODIFICATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD28; ARGININE; CELL DIFFERENTIATION; HUMANS; METHYLATION; MODELS, IMMUNOLOGICAL; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 33646163933     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2006.03.001     Document Type: Review

References (53)

1. Pawson T. Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell 116 (2004) 191-203
2. McBride A.E., and Silver P.A. State of the arg: protein methylation at arginine comes of age. Cell 106 (2001) 5-8
3. Bedford M.T., and Richard S. Arginine methylation an emerging regulator of protein function. Mol Cell 18 (2005) 263-272. This recent and thorough review describes the current knowledge of protein arginine methylation, focusing on the implication of this type of post-translational modification on protein and cellular functions.
4. Gary J.D., and Clarke S. RNA and protein interactions modulated by protein arginine methylation. Prog Nucleic Acid Res Mol Biol 61 (1998) 65-131
5. Ong S.E., Mittler G., and Mann M. Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. Nat Methods 1 (2004) 119-126. This original paper reports a technical approach that uses heavy methyl stable isotope labeling by amino acids in cell culture (SILAC) coupled to LC-mass spectrometry in order to identify in vivo methylation sites. Incorporation of heavy methyl groups into in vivo methylation sites led the characterization of 59 methylation sites after mass spectrometry analyses.
6. Boisvert F.M., Cote J., Boulanger M.C., and Richard S. A proteomic analysis of arginine-methylated protein complexes. Mol Cell Proteomics 2 (2003) 1319-1330
7. Blanchet F., Cardona A., Letimier F.A., Hershfield M.S., and Acuto O. CD28 costimulatory signal induces protein arginine methylation in T cells. J Exp Med 202 (2005) 371-377. This article describes the first evidence that arginine methylation is involved in early T cell signal transduction upon CD28 co-stimulation. The authors show that CD28 engagement increases protein arginine methyltransferase activity. They also describe the arginine methylation of Vav-1, the modified form of which resides in the nuclear compartment.
8. Lee J., and Bedford M.T. PABP1 identified as an arginine methyltransferase substrate using high-density protein arrays. EMBO Rep 3 (2002) 268-273
9. Cote J., and Richard S. Tudor domains bind symmetrical dimethylated arginines. J Biol Chem 280 (2005) 28476-28483. TUDOR domains were previously described to bind nucleic acids and methylated lysines. This article provides the first evidence of affinity binding between the TUDOR domain and methylated arginine.
10. Katz J.E., Dlakic M., and Clarke S. Automated identification of putative methyltransferases from genomic open reading frames. Mol Cell Proteomics 2 (2003) 525-540
11. Zhang X., and Cheng X. Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides. Structure 11 (2003) 509-520
12. Lin W.J., Gary J.D., Yang M.C., Clarke S., and Herschman H.R. The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J Biol Chem 271 (1996) 15034-15044
13. Singh V., Miranda T.B., Jiang W., Frankel A., Roemer M.E., Robb V.A., Gutmann D.H., Herschman H.R., Clarke S., and Newsham I.F. DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo. Oncogene 23 (2004) 7761-7771
14. Pal S., Vishwanath S.N., Erdjument-Bromage H., Tempst P., and Sif S. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol Cell Biol 24 (2004) 9630-9645
15. Xu C., and Henry M.F. Nuclear export of hnRNP Hrp1p and nuclear export of hnRNP Npl3p are linked and influenced by the methylation state of Npl3p. Mol Cell Biol 24 (2004) 10742-10756
16. Pawlak M.R., Scherer C.A., Chen J., Roshon M.J., and Ruley H.E. Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable. Mol Cell Biol 20 (2000) 4859-4869
17. Qi C., Chang J., Zhu Y., Yeldandi A.V., Rao S.M., and Zhu Y.J. Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor α. J Biol Chem 277 (2002) 28624-28630
18. Kzhyshkowska J., Schutt H., Liss M., Kremmer E., Stauber R., Wolf H., and Dobner T. Heterogeneous nuclear ribonucleoprotein E1B-AP5 is methylated in its Arg-Gly-Gly (RGG) box and interacts with human arginine methyltransferase HRMT1L1. Biochem J 358 (2001) 305-314
19. Frankel A., and Clarke S. PRMT3 is a distinct member of the protein arginine N-methyltransferase family. Conferral of substrate specificity by a zinc-finger domain. J Biol Chem 275 (2000) 32974-32982
20. Pahlich S., Bschir K., Chiavi C., Belyanskaya L., and Gehring H. Different methylation characteristics of protein arginine methyltransferase 1 and 3 toward the ewing sarcoma protein and a peptide. Proteins 61 (2005) 164-175
21. Swiercz R., Person M.D., and Bedford M.T. Ribosomal protein S2 is a substrate for mammalian protein arginine methyltransferase 3 (PRMT3). Biochem J 386 (2004) 85-91
22. Chen D., Ma H., Hong H., Koh S.S., Huang S.M., Schurter B.T., Aswad D.W., and Stallcup M.R. Regulation of transcription by a protein methyltransferase. Science 284 (1999) 2174-2177
23. Schurter B.T., Koh S.S., Chen D., Bunick G.J., Harp J.M., Hanson B.L., Henschen-Edman A., Mackay D.R., Stallcup M.R., and Aswad D.W. Methylation of histone H3 by coactivator-associated arginine methyltransferase 1. Biochemistry 40 (2001) 5747-5756
24. Yadav N., Lee J., Kim J., Shen J., Hu M.C., Aldaz C.M., and Bedford M.T. Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice. Proc Natl Acad Sci USA 100 (2003) 6464-6468
25. Chen S.L., Loffler K.A., Chen D., Stallcup M.R., and Muscat G.E. The coactivator-associated arginine methyltransferase is necessary for muscle differentiation: CARM1 coactivates myocyte enhancer factor-2. J Biol Chem 277 (2002) 4324-4333
26. Covic M., Hassa P.O., Saccani S., Buerki C., Meier N.I., Lombardi C., Imhof R., Bedford M.T., Natoli G., and Hottiger M.O. Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-κB-dependent gene expression. Embo J 24 (2005) 85-96. This study shows for the first time that TLRs and TNF receptor utilize PRMT4 to express a subset of NF-κB-dependent genes. Methyltransferase activity of PRMT4, in synergy with p300 acetyltransferase activity, drives gene transcription controlled by NF-κB.
27. Kim J., Lee J., Yadav N., Wu Q., Carter C., Richard S., Richie E., and Bedford M.T. Loss of CARM1 results in hypomethylation of thymocyte cyclic AMP-regulated phosphoprotein and deregulated early T cell development. J Biol Chem 279 (2004) 25339-25344. This follow-up to the previous paper [24] describes a direct implication of PRMT4 on thymopoiesis. PRMT4 knockout mice present a DN1 to DN2 blockade in T cell development correlated with hypomethylation of the PRMT4 substrate TARPP.
28. Friesen W.J., Paushkin S., Wyce A., Massenet S., Pesiridis G.S., Van Duyne G., Rappsilber J., Mann M., and Dreyfuss G. The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins. Mol Cell Biol 21 (2001) 8289-8300
29. Frankel A., Yadav N., Lee J., Branscombe T.L., Clarke S., and Bedford M.T. The novel human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme displaying unique substrate specificity. J Biol Chem 277 (2002) 3537-3543
30. Boulanger M.C., Liang C., Russell R.S., Lin R., Bedford M.T., Wainberg M.A., and Richard S. Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression. J Virol 79 (2005) 124-131
31. Miranda T.B., Webb K.J., Edberg D.D., Reeves R., and Clarke S. Protein arginine methyltransferase 6 specifically methylates the nonhistone chromatin protein HMGA1a. Biochem Biophys Res Commun 336 (2005) 831-835
32. Lee J., Sayegh J., Daniel J., Clarke S., and Bedford M.T. PRMT8, a new membrane-bound tissue-specific member of the protein arginine methyltransferase family. J Biol Chem 280 (2005) 32890-32896
33. Cimato T.R., Tang J., Xu Y., Guarnaccia C., Herschman H.R., Pongor S., and Aletta J.M. Nerve growth factor-mediated increases in protein methylation occur predominantly at type I arginine methylation sites and involve protein arginine methyltransferase 1. J Neurosci Res 67 (2002) 435-442
34. Cimato T.R., Ettinger M.J., Zhou X., and Aletta J.M. Nerve growth factor-specific regulation of protein methylation during neuronal differentiation of PC12 cells. J Cell Biol 138 (1997) 1089-1103
35. Chevillard-Briet M., Trouche D., and Vandel L. Control of CBP co-activating activity by arginine methylation. EMBO J 21 (2002) 5457-5466
36. Stallcup M.R. Role of protein methylation in chromatin remodeling and transcriptional regulation. Oncogene 20 (2001) 3014-3020
37. Mowen K.A., Tang J., Zhu W., Schurter B.T., Shuai K., Herschman H.R., and David M. Arginine methylation of STAT1 modulates IFNα/β-induced transcription. Cell 104 (2001) 731-741
38. Chen W., Daines M.O., and Hershey G.K. Methylation of STAT6 modulates STAT6 phosphorylation, nuclear translocation, and DNA-binding activity. J Immunol 172 (2004) 6744-6750
39. Komyod W., Bauer U.M., Heinrich P.C., Haan S., and Behrmann I. Are STATS arginine-methylated?. J Biol Chem 280 (2005) 21700-21705
40. Li H., Park S., Kilburn B., Jelinek M.A., Henschen-Edman A., Aswad D.W., Stallcup M.R., and Laird-Offringa I.A. Lipopolysaccharide-induced methylation of HuR, an mRNA-stabilizing protein, by CARM1. Coactivator-associated arginine methyltransferase. J Biol Chem 277 (2002) 44623-44630
41. Mowen K.A., Schurter B.T., Fathman J.W., David M., and Glimcher L.H. Arginine methylation of NIP45 modulates cytokine gene expression in effector T lymphocytes. Mol Cell 15 (2004) 559-571. This is the first work to describe a functional role of arginine methylation in Th1 and Th2 cells. NIP45 was found to be methylated on its amino-terminus by PRMT1, and this methylation event was shown to modulate the interaction between NIP45 and NF-ATc2. The amino-terminal region of NIP45 is necessary for potent NIP45-induced augmentation of NF-AT transactivation and is responsible for PRMT1 coactivation of the IL-4 promoter.
42. Crabtree G.R., and Olson E.N. NFAT signaling: choreographing the social lives of cells. Cell 109 (2002) S67-S79
43. Acuto O., and Michel F. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat Rev Immunol 3 (2003) 939-951
44. Hodge M.R., Chun H.J., Rengarajan J., Alt A., Lieberson R., and Glimcher L.H. NF-AT-Driven interleukin-4 transcription potentiated by NIP45. Science 274 (1996) 1903-1905
45. Turner M., and Billadeau D.D. VAV proteins as signal integrators for multi-subunit immune-recognition receptors. Nat Rev Immunol 2 (2002) 476-486
46. Houlard M., Arudchandran R., Regnier-Ricard F., Germani A., Gisselbrecht S., Blank U., Rivera J., and Varin-Blank N. Vav1 is a component of transcriptionally active complexes. J Exp Med 195 (2002) 1115-1127
47. Klasen S., Pages F., Peyron J.-F., Cantrell D.A., and Olive D. Two distinct regions of the CD28 intracytoplasmic domain are involved in the tyrosine phosphorylation of vav and GTPase activating protein-associated p62 protein. Int Immunol 10 (1998) 481-489
48. ••] provide the first evidence that monomethylated arginines on histone H3 can be removed by PAD. Removal of the monomethylamine by PAD4 resulted in the formation of an atypical amino acid citrulline. It was also shown that conversion of unmodified arginines into citrulline by PAD4 led to competitive inhibition of PRMT4-mediated arginine methylation and gene expression.
49. ••].
50. Kubicek S., and Jenuwein T. A crack in histone lysine methylation. Cell 119 (2004) 903-906
51. Aletta J.M., Cimato T.R., and Ettinger M.J. Protein methylation: a signal event in post-translational modification. Trends Biochem Sci 23 (1998) 89-91
52. Wolos J.A., Frondorf K.A., and Esser R.E. Immunosuppression mediated by an inhibitor of S-adenosyl-L-homocysteine hydrolase. Prevention and treatment of collagen-induced arthritis. J Immunol 151 (1993) 526-534
53. Cheng D., Yadav N., King R.W., Swanson M.S., Weinstein E.J., and Bedford M.T. Small molecule regulators of protein arginine methyltransferases. J Biol Chem 279 (2004) 23892-23899